MKTX vs ORMP
MarketAxess Holdings Inc (MKTX) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported MKTX revenue for 2024-12-31 was $817.1M. Net income was $274.2M. Revenue was up 8.6% from 2023-12-31 to 2024-12-31. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
MKTX currently screens at market cap $4.00B and trailing P/E 13.3. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the MKTX and ORMP stock pages for the full models.
Not investment advice.